-
Zaiding Pharmaceutical: Ruiputinib has been approved by the state for the treatment of ROS1 positive non-small cell lung cancer patients
Southern Finance and Economics, May 13 (Xinhua) - Zaiding Pharmaceutical Hong Kong Stock Exchange announced that the National Medical Products Administration of China has approved the use of reprotin ... -
AstraZeneca lung cancer targeted drug Teresa has been approved for new indications in China
AstraZeneca announced on June 26 that the National Medical Products Administration of China officially approved Teresa& on June 18, 2024; reg; The combination of pemetrexed and platinum based chemoth ...